What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?

Chris Kenyon; Robert Colebunders

doi:10.1371/journal.pmed.1001291

Loading metrics

Open Access

Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?

Chris Kenyon ,

* E-mail: chriskenyon0@gmail.com

Affiliation Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa
⨯
Robert Colebunders

Affiliations University of Antwerp, Antwerp, Belgium, Institute of Tropical Medicine, Antwerp, Belgium
⨯

What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?

Chris Kenyon,
Robert Colebunders

Published: August 14, 2012
https://doi.org/10.1371/journal.pmed.1001291

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Pearls
Is the Subject Area "Pearls" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.